Global Map of Science - March 2010
This map is based on research-front data for the fourth bimonthly period of
2009, September 30, 2003-August 31, 2009 (sliding 6-year period). The map shows the major subject areas within fields linked together
in a network based on the same principles as our research-front maps showing
highly cited papers. To create a map of science, we start with all research
fronts in
Essential Science IndicatorsSM
from Thomson
Reuters, and compute the links between fronts based on how often they
are co-cited—that is, the frequency that current papers jointly cite two given
fronts. Successive applications of a clustering process then groups fronts into
larger aggregates. Each circle on the map represents a cluster or aggregate of
research fronts on a broad topic within that field. Annotations have been added
to this map which represent the main research themes. These appear as labels
attached to specific regions on the maps.
Additional information about Research Fronts.

Research Fronts
Label: 11 SINGLE-WALLED CARBON NANOTUBE-IONIC LIQUID PASTE MODIFIED GLASSY CARBON ELECTRODE; VERTICAL ZNO NANOWIRE ARRAYS USING TEXTURED ZNO SEEDS; ELECTROCHEMICALLY FUNCTIONALIZED SINGLE-WALLED CARBON NANOTUBE GAS SENSOR; CARBON SINGLE-WALL CARBON NANOTUBES Discipline: Level 2 Docs: 42 Tot. Cites: 96508; Uniq. Cites: 78404 Mean Year: 2005.80
[Back to Map]
Label: 25 PLASMACYTOID DENDRITIC CELLS INDUCE HUMAN OVARIAN CARCINOMA CD8(+) REGULATORY T CELLS; PLASMACYTOID DENDRITIC CELLS PRIME IL-10-PRODUCING T REGULATORY CELLS; HUMAN MESENCHYMAL STEM CELLS MODULATE ALLOGENEIC IMMUNE CELL RESPONSES Discipline: Level 2 Docs: 31 Tot. Cites: 84107; Uniq. Cites: 67463 Mean Year: 2005.90
[Back to Map]
Label: 41 ACUTE CORONARY SYNDROME PATIENTS RECEIVING CORONARY STENTING; STABLE CORONARY DISEASE OPTIMAL MEDICAL THERAPY; UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE Discipline: Level 2 Docs: 8 Tot. Cites: 47044; Uniq. Cites: 44472 Mean Year: 2006.20
[Back to Map]
Label: 68 HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE METASTATIC BREAST CANCER ADMINISTERED; CANCER VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) SIGNALING INHIBITION CAUSES ENDOTHELIAL FENESTRATION LOSS Discipline: Level 2 Docs: 12 Tot. Cites: 47170; Uniq. Cites: 42054 Mean Year: 2005.70
[Back to Map]
Label: 13 FOREST TRANSITION LAND USE CHANGE GLOBAL UNDERSTANDING; ISOPRENE OXIDATION GLOBAL SECONDARY ORGANIC AEROSOL; ARCTIC SEA ICE DECLINE; ARCTIC WINTER SEA ICE COVER; ARCTIC SEA ICE COVER Discipline: Level 2 Docs: 25 Tot. Cites: 45857; Uniq. Cites: 39337 Mean Year: 2005.90
[Back to Map]
Label: 97 SLOAN DIGITAL SKY SURVEY Z>7 QUASAR SURVEY ADDITIONAL QUASAR DISCOVERY; SLOAN DIGITAL SKY SURVEY QUASAR SURVEY; 0 NU BETA BETA DECAY NUCLEAR MATRIX ELEMENTS; ACBAR COSMIC MICROWAVE BACKGROUND POWER SPECTRUM HIGH-RESOLUTION OBSERVATIONS Discipline: Level 2 Docs: 20 Tot. Cites: 44020; Uniq. Cites: 37325 Mean Year: 2006.30
[Back to Map]
Label: 106 CALORIE RESTRICTION INCREASES MUSCLE MITOCHONDRIAL BIOGENESIS; CALORIE RESTRICTION INDUCES MITOCHONDRIAL BIOGENESIS; CALORIE RESTRICTION PROMOTES MITOCHONDRIAL BIOGENESIS Discipline: Level 2 Docs: 10 Tot. Cites: 40617; Uniq. Cites: 36992 Mean Year: 2005.50
[Back to Map]
Label: 10 HUMAN EMBRYONIC STEM CELLS GENERATES GLUCOSE-RESPONSIVE INSULIN-SECRETING CELLS IN-VIVO; DIFFERENTIATED HUMAN EMBRYONIC STEM CELLS; HUMAN EMBRYONIC STEM CELLS EXPRESS; HUMAN EMBRYONIC STEM CELLS DERIVED; CULTURED HUMAN EMBRYONIC STEM CELLS Discipline: Level 2 Docs: 8 Tot. Cites: 32983; Uniq. Cites: 29541 Mean Year: 2006.60
[Back to Map]
Label: 29 SEROTONIN TRANSPORTER GENE PROMOTER POLYMORPHISM (5-HTTLPR) ASSOCIATION; TRIALLELIC SEROTONIN TRANSPORTER GENE PROMOTER REGION (5-HTTLPR) POLYMORPHISM; FRACTAL SMALL-WORLD HUMAN BRAIN FUNCTIONAL NETWORKS; HUMAN BRAIN PERISYLVIAN LANGUAGE NETWORKS Discipline: Level 2 Docs: 6 Tot. Cites: 32650; Uniq. Cites: 29081 Mean Year: 2005.50
[Back to Map]
Label: 12 CONTROLLED DETERMINISTIC SECURE QUANTUM COMMUNICATION USING FIVE-QUBIT ENTANGLED STATES; HIGH-SPEED LINEAR OPTICS QUANTUM COMPUTING USING ACTIVE FEED-FORWARD; CHARGE-BASED QUANTUM COMPUTING USING SINGLE DONORS Discipline: Level 2 Docs: 12 Tot. Cites: 31114; Uniq. Cites: 27706 Mean Year: 2005.80
[Back to Map]
Label: 51 CHIRAL BRONSTED ACID-CATALYZED DIRECT ASYMMETRIC MANNICH REACTION; ASYMMETRIC PHASE-TRANSFER CATALYSIS UTILIZING CHIRAL QUATERNARY AMMONIUM SALTS; CHIRAL N-HETEROCYCLIC CARBENE CATALYZED STAUDINGER REACTION Discipline: Level 2 Docs: 7 Tot. Cites: 26207; Uniq. Cites: 23266 Mean Year: 2006.20
[Back to Map]
Label: 63 EFFICIENT THIN-FILM ORGANIC SOLAR CELLS; HIGH THERMAL STABLE FLUORENE DERIVATIVE HIGHLY EFFICIENT NON-DOPED BLUE ORGANIC LIGHT-EMITTING DIODES; EFFICIENT WHITE ORGANIC LIGHT-EMITTING DEVICES; ORGANIC SMALL MOLECULE SOLAR CELLS Discipline: Level 2 Docs: 10 Tot. Cites: 24292; Uniq. Cites: 22127 Mean Year: 2005.70
[Back to Map]
Label: 82 FIMBRIN ACTIN-BINDING DOMAIN 2 C-N-TERMINI GREEN FLUORESCENT PROTEIN FUSION TRANSGENIC ARABIDOPSIS PLANT EXPRESSION ACTIN FILAMENT IMPROVED IMAGING Discipline: Level 2 Docs: 18 Tot. Cites: 26452; Uniq. Cites: 20188 Mean Year: 2005.40
[Back to Map]
Label: 205 ENGINEERING BONE-LIKE TISSUE IN-VITRO USING HUMAN BONE MARROW STEM CELLS; BONE TISSUE ENGINEERING USING HUMAN MESENCHYMAL STEM CELLS; IN-VITRO TISSUE-ENGINEERED BONE-LIKE STRUCTURES USING HUMAN MESENCHYMAL STEM CELLS Discipline: Level 2 Docs: 11 Tot. Cites: 18436; Uniq. Cites: 16275 Mean Year: 2005.20
[Back to Map]
Label: 61 MAPPING H5N1 HIGHLY PATHOGENIC AVIAN INFLUENZA RISK; HIGHLY PATHOGENIC AVIAN INFLUENZA H5N1; HIGHLY PATHOGENIC H5N1 AVIAN INFLUENZA; HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS (H5NI); HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS ISOLATES Discipline: Level 2 Docs: 3 Tot. Cites: 16138; Uniq. Cites: 15592 Mean Year: 2005.30
[Back to Map]
Label: 45 ESTIMATING NATURAL POPULATION GENETIC PARAMETERS USING ANIMAL MODEL; MANAGEMENT UNIT IDENTIFICATION USING POPULATION GENETIC DATA; 21 NONCODING CHLOROPLAST DNA SEQUENCE RELATIVE UTILITY PHYLOGENETIC ANALYSIS; GENETIC POPULATION STRUCTURE Discipline: Level 2 Docs: 6 Tot. Cites: 16504; Uniq. Cites: 15155 Mean Year: 2005.60
[Back to Map]
Label: 64 AMYLOID BETA PROTEIN DIMER-CONTAINING HUMAN CSF DISRUPTS SYNAPTIC PLASTICITY; HUMAN PRION PROTEIN AMYLOID FIBRILS; AMYLOID BETA PROTEIN IMMUNOTHERAPY NEUTRALIZES; ALZHEIMER'S DISEASE MOUSE MODEL; ALZHEIMER'S DISEASE GENETICS Discipline: Level 2 Docs: 2 Tot. Cites: 11369; Uniq. Cites: 11244 Mean Year: 2006.00
[Back to Map]
Label: 17 CORPORATE CAPITAL STRUCTURE CORPORATE GOVERNANCE; FIRM RESOURCE-BASED VIEW EMPIRICAL RESEARCH FUTURE RESEARCH ASSESSMENT-SUGGESTIONS; CROSS-CULTURAL ORGANIZATIONAL BEHAVIOR RESEARCH Discipline: Level 2 Docs: 8 Tot. Cites: 11774; Uniq. Cites: 11132 Mean Year: 2005.80
[Back to Map]
Label: 183 EARLY EOCENE GLOBAL WARMING EVENTS; GREENHOUSE GASES TRIGGERING EARLY JURASSIC GLOBAL WARMING; INITIAL EOCENE GLOBAL WARMING; ZIRCON ISOTOPE EVIDENCE; EARLY JURASSIC (TOARCIAN) OCEANIC ANOXIC EVENT Discipline: Level 2 Docs: 3 Tot. Cites: 9535; Uniq. Cites: 9285 Mean Year: 2005.60
[Back to Map]
Label: 163 P53 ISOFORMS REGULATES P53 TRANSCRIPTIONAL ACTIVITY; ATM-MRE11 COMPLEX RECOGNIZE SIGNAL DNA DOUBLE-STRAND BREAKS; CHROMOSOMAL RAG-MEDIATED DNA DOUBLE-STRAND BREAKS; DNA DOUBLE-STRAND BREAKS REJOINING; EXO1 RESECT DNA DOUBLE-STRAND BREAK ENDS Discipline: Level 2 Docs: 3 Tot. Cites: 9765; Uniq. Cites: 9232 Mean Year: 2005.80
[Back to Map]
Label: 93 PROTEIN FORCE FIELDS; MIXED QUANTUM MECHANICS/MOLECULAR MECHANICS (QM/MM) METHODS; GLOBAL DOWNHILL PROTEIN FOLDING ATOM-BY-ATOM ANALYSIS; AB INITIO QUANTUM MECHANICS/MOLECULAR MECHANICS METHODS; SIMULATION PREDICT PROTEIN FOLDING KINETICS Discipline: Level 2 Docs: 4 Tot. Cites: 9658; Uniq. Cites: 9000 Mean Year: 2005.50
[Back to Map]
Label: 226 HEPATITIS B E ANTIGEN-POSITIVE CHRONIC HEPATITIS B; CHRONIC HEPATITIS C VIRUS GENOTYPE 2/3 INFECTION; CHRONIC HEPATITIS C VIRUS INFECTION; CHRONIC HEPATITIS B VIRUS INFECTION; CHRONIC HEPATITIS C VIRUS GENOTYPES 2 Discipline: Level 2 Docs: 2 Tot. Cites: 9200; Uniq. Cites: 8958 Mean Year: 2006.50
[Back to Map]
Label: 14 REVERSIBLE ADDITION-FRAGMENTATION CHAIN TRANSFER (RAFT) RADICAL POLYMERIZATION; REVERSIBLE ADDITION-FRAGMENTATION CHAIN TRANSFER (RAFT) POLYMERIZATION RATE RETARDATION; SURFACE REVERSIBLE ADDITION-FRAGMENTATION CHAIN TRANSFER POLYMERIZATION Discipline: Level 2 Docs: 3 Tot. Cites: 9441; Uniq. Cites: 8957 Mean Year: 2006.00
[Back to Map]
Label: 184 BIPOLAR I DISORDER (INTERNATIONAL TRIAL 126); PEDIATRIC BIPOLAR DISORDER; BIPOLAR I DISORDER RESPONDING; SCHIZOPHRENIA PATIENT TREATMENT PRACTICE GUIDELINE; BIPOLAR DISORDER FOLLOWING FIRST HOSPITALIZATION Discipline: Level 2 Docs: 3 Tot. Cites: 8109; Uniq. Cites: 7710 Mean Year: 2005.70
[Back to Map]
Label: 347 SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS; CHRONIC OBSTRUCTIVE LUNG DISEASE; GAINING OPTIMAL ASTHMA CONTROL STUDY; ASTHMA CONTROL TEST Discipline: Level 2 Docs: 2 Tot. Cites: 7889; Uniq. Cites: 7646 Mean Year: 2005.80
[Back to Map]
Label: 107 DUCTILE BULK METALLIC GLASSES; "WORK-HARDENABLE" DUCTILE BULK METALLIC GLASS; SUPER PLASTIC BULK METALLIC GLASSES; MECHANISM-BASED STRAIN GRADIENT CRYSTAL PLASTICITY; FE-BASED BULK METALLIC GLASSES Discipline: Level 2 Docs: 3 Tot. Cites: 7543; Uniq. Cites: 7287 Mean Year: 2005.30
[Back to Map]
Label: 341 HIGH PERFORMANCE PROTON EXCHANGE MEMBRANE FUEL CELL MULTIWALLED CARBON NANOTUBE HIGH LOADING-MONODISPERSED PT NANOPARTICLES; DIRECT ETHANOL PROTON EXCHANGE MEMBRANE FUEL CELLS (DE-PEMFCS) Discipline: Level 2 Docs: 3 Tot. Cites: 7458; Uniq. Cites: 6890 Mean Year: 2005.40
[Back to Map]
Label: 109 STROKE PREVENTION (VISP) RANDOMIZED CONTROLLED TRIAL; ALZHEIMER DISEASE-HIGH-DOSE B VITAMIN SUPPLEMENTATION-COGNITIVE DECLINE RANDOMIZED CONTROLLED TRIAL; PROSTATE CANCER PREVENTION TRIAL Discipline: Level 2 Docs: 4 Tot. Cites: 6886; Uniq. Cites: 6672 Mean Year: 2006.20
[Back to Map]
Label: 128 ERG SEQUENCES IDENTIFIES FATAL HUMAN PROSTATE CANCER; SCANDINAVIAN PROSTATE CANCER GROUP-4 RANDOMIZED TRIAL; LOCALIZED PROSTATE CANCER UPDATE PANEL REPORT; PROSTATE CANCER PREDICTING TUMOR AGGRESSION; PROSTATE CANCER TUMOR VOLUME Discipline: Level 2 Docs: 3 Tot. Cites: 6651; Uniq. Cites: 6414 Mean Year: 2006.30
[Back to Map]
Label: 147 HOSPITAL QUALITY ALLIANCE PROGRAM US HOSPITAL CARE; HEALTH CARE DISPARITIES QUALITY REPORTING-PAY-FOR-PERFORMANCE EFFECTS; HEALTH CARE QUALITY; ACCOUNTABLE CARE ORGANIZATION CREATION EXTENDED HOSPITAL MEDICAL STAFF; ADDRESS HEALTH CARE DISPARITIES Discipline: Level 2 Docs: 7 Tot. Cites: 6694; Uniq. Cites: 6403 Mean Year: 2006.10
[Back to Map]
Label: 31 PREVIOUSLY UNTREATED SYMPTOMATIC MULTIPLE MYELOMA; PREVIOUSLY UNTREATED MULTIPLE MYELOMA; HISTONE DEACETYLASE INHIBITOR LAQ824 ENHANCES APO-2L/TUMOR NECROSIS FACTOR-RELATED APOPTOSIS INDUCING LIGAND-INDUCED DEATH INDUCING SIGNALING COMPLEX ACTIVITY Discipline: Level 2 Docs: 3 Tot. Cites: 6673; Uniq. Cites: 6300 Mean Year: 2006.10
[Back to Map]
Label: 401 TOTAL ANTIOXIDANT CAPACITY INDEX; SELECTED PLANT ESSENTIAL OILS; 11 ESSENTIAL OILS; SAVORY ESSENTIAL OILS; SIX ESSENTIAL OILS Discipline: Level 2 Docs: 4 Tot. Cites: 6407; Uniq. Cites: 6155 Mean Year: 2005.70
[Back to Map]
Label: 44 BIODIESEL CONTENT DETERMINATION BLENDING MINERAL DIESEL FUEL USING INFRARED SPECTROSCOPY-MULTIVARIATE CALIBRATION; FIRST-ORDER REACTION NETWORK STOCHASTIC ANALYSIS; BIOCHEMICAL NETWORK STOCHASTIC SIMULATOR (BIONETS) Discipline: Level 2 Docs: 2 Tot. Cites: 6004; Uniq. Cites: 5938 Mean Year: 2005.50
[Back to Map]
Label: 105 TUMOUR NECROSIS FACTOR ANTAGONISTS; GLOBAL PHASE III RANDOMIZED CONTROLLED TRIAL; CONTROLLED PHASE III TRIAL; TUMOUR NECROSIS FACTOR BLOCKERS; TUMOR NECROSIS FACTOR ANTAGONISTS Discipline: Level 2 Docs: 3 Tot. Cites: 6232; Uniq. Cites: 5874 Mean Year: 2006.20
[Back to Map]
Label: 39 BACTERIAL MULTIDRUG ABC TRANSPORTER; MULTIDRUG ABC TRANSPORTER SAV1866; MULTIDRUG RESISTANCE TRANSPORTER GENE; PUTATIVE METAL-CHELATE-TYPE ABC TRANSPORTER; BACTERIAL OUTER MEMBRANE PERMEABILITY REVISITED Discipline: Level 2 Docs: 3 Tot. Cites: 5940; Uniq. Cites: 5759 Mean Year: 2005.30
[Back to Map]
Label: 98 -INDEPENDENT MODES REGULATING CA2+ RELEASE-ACTIVATED CA2+ CHANNEL ACTIVITY; REGULATE CA2+ RELEASE-ACTIVATED CA2+ CHANNEL ACTIVITY; TRANSIENT RECEPTOR POTENTIAL VANILLOID 4 ION CHANNEL; CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL COMPONENTS Discipline: Level 2 Docs: 4 Tot. Cites: 5653; Uniq. Cites: 5363 Mean Year: 2006.20
[Back to Map]
Label: 58 COMPARING MICROBIAL COMMUNITY DIVERSITY; MICROBIAL COMMUNITY GENE EXPRESSION; MICROBIAL DIVERSITY; MICROBIAL SPECIES; RECENT LARGE 16S RRNA GENE CLONE LIBRARIES CONTAIN CHIMERAS Discipline: Level 2 Docs: 4 Tot. Cites: 5548; Uniq. Cites: 5294 Mean Year: 2005.30
[Back to Map]
Label: 78 HUMAN IMMUNODEFICIENCY VIRUS (HIV)-INFECTED ADULTS RECEIVING ANTIRETROVIRAL THERAPY; HIV-INFECTED UGANDAN ADULTS RECEIVING ANTIRETROVIRAL TREATMENT; HUMAN IMMUNODEFICIENCY VIRUS INTEGRASE INHIBITOR ELVITEGRAVIR (JTK-303/GS-9137) Discipline: Level 2 Docs: 2 Tot. Cites: 5263; Uniq. Cites: 5080 Mean Year: 2006.10
[Back to Map]
Label: 69 WOMEN'S HEALTH INITIATIVE RANDOMIZED CONTROLLED TRIAL; WOMEN'S HEALTH INITIATIVE RANDOMIZED TRIAL; WOMEN'S HEALTH INITIATIVE CLINICAL TRIAL; ESTROGEN RECEPTOR G PROTEIN-COUPLED RECEPTOR Discipline: Level 2 Docs: 2 Tot. Cites: 4801; Uniq. Cites: 4675 Mean Year: 2005.90
[Back to Map]
Label: 149 WATER INTERFACIAL STRUCTURE REVEALED; INTERFACIAL WATER STRUCTURE; AMIDE I TWO-DIMENSIONAL INFRARED SPECTROSCOPY; ALIGNED MULTIWALLED CARBON NANOTUBE MEMBRANES; TRANSIENT TWO-DIMENSIONAL INFRARED SPECTROSCOPY Discipline: Level 2 Docs: 2 Tot. Cites: 4677; Uniq. Cites: 4571 Mean Year: 2005.50
[Back to Map]
Label: 40 ORAL DIRECT FACTOR XA INHIBITOR RIVAROXABAN (BAY 59-7939); ORAL DIRECT FACTOR XA INHIBITOR APIXABAN; ODIXA-DVT (ORAL DIRECT FACTOR XA INHIBITOR BAY 59-7939; THE BIRMINGHAM ATRIAL FIBRILLATION TREATMENT OF THE AGED STUDY Discipline: Level 2 Docs: 2 Tot. Cites: 4670; Uniq. Cites: 4530 Mean Year: 2005.50
[Back to Map]
Label: 46 UNTREATED COFFEE HUSK BIOSORBENT AQUEOUS SOLUTION HEAVY METAL REMOVAL; AQUEOUS SOLUTION DYE REMOVAL USING FLY ASH-RED MUD; HEVEA BRASILINESIS SAWDUST ACTIVATED CARBON AQUEOUS SOLUTION CHROMIUM(VI) ADSORPTION; BIOPOLYMER-BASED ANTIMICROBIAL PACKAGING Discipline: Level 2 Docs: 2 Tot. Cites: 4395; Uniq. Cites: 4337 Mean Year: 2005.80
[Back to Map]
Label: 259 FOCAL ADHESION KINASE; RHO-KINASE SUPPRESSES ANGIOTENSIN II-INDUCED CARDIOVASCULAR HYPERTROPHY; RHO GTPASE BIOCHEMISTRY-BIOLOGY; RHO GTPASES LEAD; CARDIOVASCULAR PHYSIOLOGY Discipline: Level 2 Docs: 2 Tot. Cites: 4104; Uniq. Cites: 4031 Mean Year: 2004.60
[Back to Map]
Label: 255 SPIN-1/2 KAGOME LATTICE ANTIFERROMAGNET ZNCU3(OH)(6)CL-2; S=1/2 KAGOME LATTICE ZNCU3(OH)(6)CL-2; IRON-BASED LAYERED SUPERCONDUCTOR; QUANTUM KAGOME ANTIFERROMAGNET ZNCU3(OH)(6)CL-2; UNDERDOPED HIGH-T-C SUPERCONDUCTOR Discipline: Level 2 Docs: 3 Tot. Cites: 4032; Uniq. Cites: 3903 Mean Year: 2006.80
[Back to Map]
Label: 260 NEGATIVE INDEX MATERIALS USING SIMPLE SHORT WIRE PAIRS; ARBITRARY DUAD-BAND COMPONENTS USING COMPOSITE RIGHT/LEFT-HANDED TRANSMISSION LINES; FAR-FIELD SUBDIFFRACTION OPTICAL MICROSCOPY USING METAMATERIAL CRYSTALS Discipline: Level 2 Docs: 3 Tot. Cites: 4151; Uniq. Cites: 3747 Mean Year: 2004.90
[Back to Map]
Label: 80 PARKINSON'S DISEASE SUGGEST HOST-TO-GRAFT DISEASE PROPAGATION; SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION; BILATERAL DEEP BRAIN STIMULATION; SPORADIC PARKINSON'S DISEASE; PARKINSON'S DISEASE SURVIVE Discipline: Level 2 Docs: 4 Tot. Cites: 3807; Uniq. Cites: 3560 Mean Year: 2006.10
[Back to Map]
Label: 303 PROPHYLACTIC QUADRIVALENT HUMAN PAPILLOMAVIRUS (HPV) TYPES 6/11/16/18 L1 VIRUS-LIKE PARTICLE (VLP) VACCINE; PROPHYLACTIC QUADRIVALENT HUMAN PAPILLOMAVIRUS TYPES 6/11/16/18 L1 VIRUS-LIKE PARTICLE VACCINE; HUMAN PAPILLOMAVIRUS VACCINE Discipline: Level 2 Docs: 2 Tot. Cites: 3358; Uniq. Cites: 3347 Mean Year: 2007.30
[Back to Map]
Label: 55 MONOCROTALINE-INDUCED PULMONARY ARTERIAL HYPERTENSION USING BONE MARROW-DERIVED ENDOTHELIAL-LIKE PROGENITOR CELLS; MILDLY SYMPTOMATIC PULMONARY ARTERIAL HYPERTENSION; HIV-RELATED PULMONARY ARTERIAL HYPERTENSION Discipline: Level 2 Docs: 3 Tot. Cites: 3334; Uniq. Cites: 3230 Mean Year: 2006.00
[Back to Map]
Label: 290 LYSOPHOSPHATIDIC ACID RECEPTOR LPA(1); G(Q)-COUPLED LYSOPHOSPHATIDIC ACID RECEPTOR; SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS LESIONS; RELAPSING-REMITTING MULTIPLE SCLEROSIS Discipline: Level 2 Docs: 2 Tot. Cites: 3252; Uniq. Cites: 3193 Mean Year: 2005.70
[Back to Map]
Label: 148 STABLE BIONIC SUPERHYDROPHOBIC SURFACES; SUPERHYDROPHOBIC BIONIC SURFACES; ROUGH THREE-DIMENSIONAL SUPERHYDROPHOBIC SURFACES; BIOMIMETIC SUPERHYDROPHOBIC SURFACES; FABRICATING SUPERHYDROPHOBIC SURFACES Discipline: Level 2 Docs: 2 Tot. Cites: 2899; Uniq. Cites: 2832 Mean Year: 2005.80
[Back to Map]
Label: 292 QUANTITATIVE LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; QUANTITATIVE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-ELECTROSPRAY-TANDEM MASS SPECTROMETRY MATRIX EFFECTS; WATER USING LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY Discipline: Level 2 Docs: 3 Tot. Cites: 2810; Uniq. Cites: 2710 Mean Year: 2006.50
[Back to Map]
Label: 316 AMERICAN RED CROSS ADULT BLOOD DONORS; AMERICAN RED CROSS BLOOD DONORS; POLYBROMINATED DIPHENYL ETHER CONGENERS BDE 99; POLYBROMINATED DIPHENYL ETHER FLAME RETARDANTS Discipline: Level 2 Docs: 2 Tot. Cites: 2782; Uniq. Cites: 2689 Mean Year: 2006.50
[Back to Map]
Label: 194 ANTIBODY-MEDIATED RENAL ALLOGRAFT REJECTION; DECEASED-DONOR RENAL TRANSPLANTATION; CARDIAC ALLOGRAFT RECIPIENTS USING GENE EXPRESSION PROFILING; CARDIAC TRANSPLANTATION; HIGHLY SENSITIZED RENAL TRANSPLANT PATIENTS Discipline: Level 2 Docs: 2 Tot. Cites: 2744; Uniq. Cites: 2671 Mean Year: 2006.00
[Back to Map]
Label: 240 ATP MEDIATES LOCAL BRAIN INJURY INVIVO RAPID MICROGLIAL RESPONSE; PROLIFERATING MICROGLIAL CELLS EXACERBATES ISCHEMIC INJURY; RESTING MICROGLIAL CELLS; NEURONAL ANION GRADIENT UNDERLYING NEUROPATHIC PAIN; NEUROPATHIC PAIN TRIAD Discipline: Level 2 Docs: 3 Tot. Cites: 2843; Uniq. Cites: 2669 Mean Year: 2005.90
[Back to Map]
Label: 216 CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA; ACUTE MYELOID LEUKEMIA CARRYING CYTOPLASMIC/MUTATED NUCLEOPHOSMIN (NPMC(+) AML); ACUTE MYELOID LEUKEMIA BEARING CYTOPLASMIC MUTATED NUCLEOPHOSMIN; ACUTE MYELOID LEUKEMIA (AML) Discipline: Level 2 Docs: 3 Tot. Cites: 2496; Uniq. Cites: 2340 Mean Year: 2006.50
[Back to Map]
Label: 139 WITHIN-ARRAY REPLICATE SPOTS USE ASSESSING MICROARRAY EXPERIMENT DIFFERENTIAL EXPRESSION; AFFYMETRIX GENECHIP EXPRESSION; CDNA MICROARRAY EXPERIMENT FACTORIAL-TIME COURSE DESIGNS; PRODUCING AFFYMETRIX EXPRESSION SCORES; CDNA MICROARRAY EXPERIMENTS Discipline: Level 2 Docs: 2 Tot. Cites: 2290; Uniq. Cites: 2258 Mean Year: 2004.50
[Back to Map]
Label: 27 PROTEIN REDOX REGULATION; GLUTATHIONE-DEPENDENT REDOX ENZYMES; REVERSIBLE PROTEIN S-GLUTATHIONYLATION; REVERSIBLE PROTEIN GLUTATHIONYLATION; NOX ENZYMES Discipline: Level 2 Docs: 2 Tot. Cites: 2091; Uniq. Cites: 2043 Mean Year: 2005.40
[Back to Map]
Label: 120 APICOMPLEXAN CRYPTOSPORIDIUM PARVUM COMPLETE GENOME SEQUENCE; MACRONUCLEAR GENOME SEQUENCE; 2-MEGABASE GENOME SEQUENCE; DRAFT GENOME SEQUENCE; ENTAMOEBA HISTOLYTICA GENOME Discipline: Level 2 Docs: 3 Tot. Cites: 2149; Uniq. Cites: 2005 Mean Year: 2005.70
[Back to Map]
Label: 110 POST-MATING SEXUAL SELECTION INCREASES LIFETIME FITNESS; MATING-FERTILIZATION SEXUAL CONFLICT OVERVIEW; MELANIN-VERSUS CAROTENOID-BASED SEXUAL SIGNALS; MATERNAL EFFECT ADAPTIVE; SECONDARY SEXUAL TRAIT Discipline: Level 2 Docs: 2 Tot. Cites: 2013; Uniq. Cites: 1959 Mean Year: 2005.70
[Back to Map]
Label: 102 TYPE 2 DIABETES MELLITUS OLDER PATIENT HYPOGLYCEMIC EPISODES-DEMENTIA RISK ASSOCIATION; MIDLIFE CARDIOVASCULAR RISK FACTORS; REDUCED RISK; VOLUNTARY EXERCISE DECREASES AMYLOID LOAD; EXERCISE BUILDS BRAIN HEALTH Discipline: Level 2 Docs: 2 Tot. Cites: 1972; Uniq. Cites: 1922 Mean Year: 2006.50
[Back to Map]
Label: 112 RETHINKING RELATIONAL ECONOMIC GEOGRAPHY; EVOLUTIONARY ECONOMIC GEOGRAPHY; REGIONAL ECONOMIC EVOLUTION; REGIONAL ECONOMIC GROWTH; CREATIVE CLASS Discipline: Level 2 Docs: 2 Tot. Cites: 1939; Uniq. Cites: 1920 Mean Year: 2006.30
[Back to Map]
Label: 258 PRINTED COVALENT GLYCAN ARRAY DIVERSE GLYCAN BINDING PROTEIN LIGAND PROFILING; CHEMICAL PROTEIN MODIFICATION; SITE-SELECTIVE PROTEIN MODIFICATION; MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY Discipline: Level 2 Docs: 2 Tot. Cites: 1806; Uniq. Cites: 1785 Mean Year: 2006.90
[Back to Map]
Label: 247 SMALL RNA BINDING; CRP-ACTIVATED SMALL NONCODING REGULATORY RNA CYAR (RYEE); SMALL RNA REGULATORS; 70S RIBOSOME COMPLEXED; HFQ-BINDING SMALL RNAS Discipline: Level 2 Docs: 2 Tot. Cites: 1726; Uniq. Cites: 1691 Mean Year: 2006.50
[Back to Map]
Label: 104 GOA DATABASE 2009 INTEGRATED GENE ONTOLOGY ANNOTATION RESOURCE; CATH DOMAIN STRUCTURE DATABASE; INTEGRATIVE PROTEIN SIGNATURE DATABASE; CONSERVED DOMAIN DATABASE; NUCLEIC ACIDS RESEARCH ANNUAL DATABASE ISSUE Discipline: Level 2 Docs: 3 Tot. Cites: 1744; Uniq. Cites: 1667 Mean Year: 2007.50
[Back to Map]
Label: 309 ALTERNATIVE PRE-MESSENGER RNA SPLICING MECHANISMS; ALTERNATIVE SPLICING ISOFORMS USING GENERATIVE MODEL; UNBALANCED ALTERNATIVE SPLICING CANCER SIGNIFICANCE; UNDERSTANDING ALTERNATIVE SPLICING; ALTERNATIVE PRE-MRNA SPLICING Discipline: Level 2 Docs: 2 Tot. Cites: 1551; Uniq. Cites: 1523 Mean Year: 2006.20
[Back to Map]
Label: 140 ALKALINE DIRECT BOROHYDRIDE FUEL CELL; VIABLE HYDROGEN STORAGE SYSTEM; MG-LI-N-H HYDROGEN STORAGE SYSTEM; PROMISING HYDROGEN STORAGE SYSTEM; HIGH-PERFORMANCE PLANAR BOROHYDRIDE FUEL CELL MODULES Discipline: Level 2 Docs: 3 Tot. Cites: 1570; Uniq. Cites: 1461 Mean Year: 2006.70
[Back to Map]
Label: 143 EXTREMELY LOW BIRTH WEIGHT INFANTS; EXTREMELY PRETERM BIRTH; PRETERM INFANTS; EARLY INHALED NITRIC OXIDE THERAPY; CEREBRAL WHITE MATTER INJURY Discipline: Level 2 Docs: 2 Tot. Cites: 1493; Uniq. Cites: 1460 Mean Year: 2005.50
[Back to Map]
Label: 331 COMMON NOVEL CTP2C19 GENE VARIANT CAUSES ULTRARAPID DRUG METABOLISM RELEVANT; THYMIDYLATE SYNTHASE GENE; CODEINE INTOXICATION ULTRARAPID CYP2D6 METABOLISM ASSOCIATION; ADJUVANT BREAST CANCER TREATMENT; THYMIDYLATE SYNTHASE EXPRESSION Discipline: Level 2 Docs: 2 Tot. Cites: 1495; Uniq. Cites: 1450 Mean Year: 2005.10
[Back to Map]
Label: 133 SUPPOSED ANCIENT ASEXUAL ARBUSCULAR MYCORRHIZAL FUNGUS; ARBUSCULAR MYCORRHIZAL FUNGUS GLOMUS INTRARADICES; DIFFERENT ARBUSCULAR MYCORRHIZAL FUNGI; ARBUSCULAR MYCORRHIZAL (AM) SYMBIOSES; ARBUSCULAR MYCORRHIZAL SYMBIOSIS Discipline: Level 2 Docs: 2 Tot. Cites: 1449; Uniq. Cites: 1402 Mean Year: 2004.90
[Back to Map]
Label: 300 VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)/VEGF RECEPTOR SYSTEM; SENTINEL LYMPH NODES PROMOTES TUMOR METASTASIS; VASCULAR ENDOTHELIAL GROWTH FACTORS; PROMOTES LYMPHATIC METASTASIS; LYMPHATIC ENDOTHELIAL PROGENITOR CELLS Discipline: Level 2 Docs: 2 Tot. Cites: 1452; Uniq. Cites: 1401 Mean Year: 2005.60
[Back to Map]
Label: 236 MULTIRACIAL IDENTITY INTEGRATION; MULTIRACIAL IDENTITY THEORY; PUBLIC MEASURES RECREATE SOCIAL WORLDS; SOCIAL COGNITION; SOCIAL JUDGMENT Discipline: Level 2 Docs: 2 Tot. Cites: 1323; Uniq. Cites: 1310 Mean Year: 2005.30
[Back to Map]
Label: 19 CHEVRONIZING FOREIGN RELATIONS LAW; DISREGARDING FOREIGN RELATIONS LAW; FOREIGN LAW; NEW CORPORATE CRIMINAL PROCEDURE; SUPREME COURT JUSTICES Discipline: Level 2 Docs: 2 Tot. Cites: 1291; Uniq. Cites: 1280 Mean Year: 2006.50
[Back to Map]
Label: 397 GENERAL HEALTH STATUS; SELF-REPORTED HEALTH STATUS; LIFE COURSE SOCIOECONOMIC FACTORS; LIFE COURSE APPROACH; LIFE COURSE PROCESSES Discipline: Level 2 Docs: 2 Tot. Cites: 1293; Uniq. Cites: 1280 Mean Year: 2005.40
[Back to Map]
Label: 285 INVITRO CYTOCHROME P450 INHIBITION DATA UTILITY PREDICTING DRUG-DRUG INTERACTIONS; ORGANIC ANION TRANSPORTING POLYPEPTIDE 2; ORGANIC ANION TRANSPORTING POLYPEPTIDES; ORGANIC ANION TRANSPORTING POLYPEPTIDE-C; HUMAN CYTOCHROME P450 3A4 Discipline: Level 2 Docs: 2 Tot. Cites: 1121; Uniq. Cites: 1093 Mean Year: 2006.20
[Back to Map]
Label: 245 HEALTH INFORMATION NATIONAL TRENDS SURVEY (HINTS); OFFLINE HEALTH INFORMATION SEEKERS; OBTAIN HEALTH INFORMATION; MEN'S HEALTH BEHAVIORS; PERCEIVED NORMATIVE HEALTH BEHAVIORS Discipline: Level 2 Docs: 2 Tot. Cites: 793; Uniq. Cites: 785 Mean Year: 2005.30
[Back to Map]
Label: 187 STOCHASTIC INTEGRATE-AND-FIRE NEURAL ENCODING MODEL; CORTICAL SPIKING NEURONS; MULTIPLE NEURAL SPIKE-TRAIN DATA; NEOCORTICAL NEURONS IN-VIVO; VISUAL CORTICAL CIRCUITS Discipline: Level 2 Docs: 2 Tot. Cites: 705; Uniq. Cites: 691 Mean Year: 2005.10
[Back to Map]
Label: 88 CAUSAL VACCINE EFFECTS; INDIRECT CAUSAL EFFECTS; CAUSAL INFERENCE USING POTENTIAL OUTCOMES; CAUSAL INFERENCE MODELS; QUANTILE TREATMENT EFFECTS Discipline: Level 2 Docs: 2 Tot. Cites: 699; Uniq. Cites: 687 Mean Year: 2005.90
[Back to Map]
Label: 89 WISTAR RATS FED GENETICALLY MODIFIED RICE EXPRESSING SNOWDROP LECTIN GALANTHUS NIVALIS (GNA); GENETICALLY MODIFIED RICE EXPRESSING CRY1AB PROTEIN (BACILLUS THURINGIENSIS TOXIN); GENETICALLY MODIFIED (GM) CROPS; FIELD-GROWN GENETICALLY MODIFIED WHEAT Discipline: Level 2 Docs: 2 Tot. Cites: 612; Uniq. Cites: 601 Mean Year: 2006.40
[Back to Map]
Label: 448 EUROPEAN LAND USE FUTURE DYNAMICS ANALYSIS; FLOODPLAIN LAND USE; ASSESSING RIVER BIOTIC CONDITION; LAND CHANGE; ECOLOGICAL CONDITION Discipline: Level 2 Docs: 2 Tot. Cites: 595; Uniq. Cites: 581 Mean Year: 2006.60
[Back to Map]
Label: 108 WHITE SPOT SYNDROME VIRUS-RESISTANT SHRIMP (LITOPENAEUS VANNAMEI); WHITE SPOT SYNDROME VIRUS (WSSV) INFECTION; TISSUE DAMAGE-INDUCED INTESTINAL STEM CELL DIVISION; PACIFIC WHITE SHRIMP LITOPENAEUS VANNAMEI; BACTERIAL INTESTINAL INFECTIONS Discipline: Level 2 Docs: 2 Tot. Cites: 523; Uniq. Cites: 518 Mean Year: 2007.20
[Back to Map]
Label: 244 TWO DISTINCT BRAIN PROCESSES; SEVERE TRAUMATIC BRAIN INJURY; BRAIN FUNCTION; FUNCTIONAL NEUROIMAGING-LAW ASSOCIATION FUTURE SCHOLARSHIP TRENDS-DIRECTIONS; FUNCTIONAL MRI LIE DETECTION Discipline: Level 2 Docs: 2 Tot. Cites: 519; Uniq. Cites: 510 Mean Year: 2006.30
[Back to Map]
Label: 127 DEFOCUSING ENERGY-CRITICAL NONLINEAR SCHRODINGER EQUATION; L-2 CRITICAL NONLINEAR SCHRODINGER EQUATION; CUBIC NON-LINEAR SCHRODINGER EQUATION; NONLINEAR SCHRODINGER EQUATIONS; CANONICAL DEFOCUSING EQUATIONS Discipline: Level 2 Docs: 2 Tot. Cites: 398; Uniq. Cites: 396 Mean Year: 2005.20
[Back to Map]
Label: 150 MEDICARE PART D PRESCRIPTION BENEFIT; MEDICARE PRESCRIPTION DRUG BENEFIT PROGRESS REPORT; BREAST CANCER PATIENT TREATMENT INFORMED DECISION; PATIENT DECISION AIDS QUALITY CRITERIA FRAMEWORK DEVELOPMENT ONLINE INTERNATIONAL DELPHI CONSENSUS PROCESS Discipline: Level 2 Docs: 2 Tot. Cites: 396; Uniq. Cites: 380 Mean Year: 2006.60
[Back to Map]
<Return to previous page
Research Front Maps - Index : Maps of Science : Global Map of Science - March 2010
|
|